На главную
Результаты поиска “U.S. Pharmaceutical Sales Statistics” за 2015
Probability-based forecasting for U.S. generic drug sales.
 
03:28
Value of Insight VoiConsulting.com.
Просмотров: 391 Value Of Insight
Pfizer, Allergan Create Largest Pharmaceutical Merger
 
01:44
Pfizer and Allergan are set to reach a $150 billion deal that would create the world's largest drug maker in terms of sales, according to the Wall Street Journal.
Просмотров: 267 CBN - The Christian Broadcasting Network
'Big pharma profiteering must be stopped' – Doctors Without Borders chief
 
02:18
The 2014 Ebola epidemic highlighted the global threat of disease. And while the need for new drugs and vaccines is clear, the research is often driven by profit. How can these opposites be reconciled, and what challenges do aid organisations face in the field? Oksana is joined by Dr Joanne Liu, the International President of Doctors Without Borders, for a dose of these issues. WATCH FULL INTERVIEW HERE: https://youtu.be/_zyEKRzrO_0 RT LIVE http://rt.com/on-air Subscribe to RT! http://www.youtube.com/subscription_center?add_user=RussiaToday Like us on Facebook http://www.facebook.com/RTnews Follow us on Twitter http://twitter.com/RT_com Follow us on Instagram http://instagram.com/rt Follow us on Google+ http://plus.google.com/+RT Listen to us on Soundcloud: https://soundcloud.com/rttv RT (Russia Today) is a global news network broadcasting from Moscow and Washington studios. RT is the first news channel to break the 1 billion YouTube views benchmark.
Просмотров: 8289 RT
My experience with jobs in pharma industry
 
14:43
Just some of my impressions on a job meeting in a pharma company
Просмотров: 48 Narednik Lobanja
Biopharmaceutical Company Beats on Earnings on Growing Sales of Depression Drug
 
00:50
Drug maker Bristol Myers (BMY) posted earnings of $0.71 per share on Tuesday, beating analyst estimates. Revenue was also higher than expected, coming in at $4.04B - a 6 percent increase on last year's numbers.The bio-pharmaceutical company benefited from increased sales of its depression treatment Abilify this quarter, but is facing competition from similar copies of the drug in the US. The New York based company was hit by the strong dollar but remains optimistic about its pipeline of immunotherapy cancer drugs and latest Hepatitis C treatments. Sales of the company's latest cancer drug Opdivo missed Wall Street expectations which knocked the stock price in this morning. Subscribe to TheStreetTV on YouTube: http://t.st/TheStreetTV For more content from TheStreet visit: http://thestreet.com Check out all our videos: http://youtube.com/user/TheStreetTV Follow TheStreet on Twitter: http://twitter.com/thestreet Like TheStreet on Facebook: http://facebook.com/TheStreet Follow TheStreet on LinkedIn: http://linkedin.com/company/theStreet Follow TheStreet on Google+: http://plus.google.com/+TheStreet
Просмотров: 85 TheStreet: Investing Strategies
The Truth About Cancer: A Global Quest - Episode 1
 
01:58:50
Welcome to Episode 1 of The Truth About Cancer: A Global Quest docu-series! We welcome you to watch this episode completely free. To sign up to be notified of the next airing of this docu-series, go here: http://bit.ly/a-global-quest-free In this episode titled "The True History of Chemotherapy and the Pharmaceutical Monopoly", we will uncover the lies of chemotherapy and learn how Big Pharma falsifies "research"-based medicine. We'll hear about the families that donated to our medical education system... and how they created a medical monopoly. Next, we visit the Hoxsey Clinic (Biomedical Center) in Tijuana, Mexico to interview doctors and patients. And we'll hear stories of children taken away from their parents and forced to undergo radiation and chemotherapy. Tune in for much more! If you would like to support our mission and own all episodes of this eye-opening docu-series, please follow this link: http://bit.ly/a-global-quest-silver --------------------------------------------------- To watch Episode 2 of "A Global Quest" docu-series for FREE, click here: http://bit.ly/a-global-quest-free Join TTAC's 1 MILLION+ FB fans: http://bit.ly/agq-fb-ttac Find us on INSTAGRAM: http://bit.ly/agq-ig-ttac Visit our website: http://bit.ly/agq-website-ttac Our mission is to educate the world, expose lies & empower people with life-saving knowledge. Help us share the truth by clicking the SHARE button above! ---------------------------------------------------------------------- Inside The Truth About Cancer Docu-Series --------------------------------------------------------------------- Doctors, researchers, experts, and survivors show you exactly how to prevent and treat cancer in our 3 original docu-series: "The Quest for the Cures”, “The Quest for the Cures Continues”, “The Truth About Cancer: A Global Quest”, and on our website: http://bit.ly/agq-website-ttac In our docu-series, you’ll travel with Ty Bollinger who lost both his mother and father to cancer (as well as 5 other family members). Ty travels the country and the globe and sits down with leading experts, doctors, researchers, and cancer conquerors to find out their proven methods for preventing and treating cancer. Please join our email list to be notified of all upcoming events (including free airings of our docu-series): http://bit.ly/join-ttac-mission Learn more about our latest docu-series “The Truth About Cancer: A Global Quest” here: http://bit.ly/a-global-quest-silver --------------------------------------- About Ty & Charlene Bollinger --------------------------------------- Ty & Charlene Bollinger are devoted Christians, health freedom advocates, health researchers, documentary film producers, and best-selling authors. After losing several family members to conventional cancer treatments, they set out to learn the truth about cancer and the cancer industry, working together tirelessly to help others to learn the truth that sets them free to live healthy, happy lives. Ty & Charlene's heartbreak and grief coupled with their firm belief that chemotherapy, radiation, and surgery were NOT the most effective treatments available for cancer patients, led them on a path of discovery. On their journey, they interviewed cutting-edge scientists, leading alternative doctors, and groundbreaking researchers to learn about hidden alternative cancer treatments. What they uncovered helped to create The Truth About Cancer and its three awe-inspiring docu-series: ”The Quest for The Cures”, “The Quest for the Cures Continues”, and “The Truth About Cancer: A Global Quest.” Ty & Charlene speak frequently at seminars, expos, conferences, and churches. Together, they host a bi-weekly internet news program: TTAC Global Health News: http://bit.ly/ghn-episodes Their message is clear: CANCER IS NOT A DEATH SENTENCE. THERE IS ALWAYS HOPE. --------------------------------------- Join Us Next Time --------------------------------------- If you enjoyed this clip, sign-up to secure your free spot at the next airing of A Global Quest here: http://bit.ly/a-global-quest-free
Просмотров: 3631834 The Truth About Cancer
Addiction
 
05:42
What causes addiction? Easy, right? Drugs cause addiction. But maybe it is not that simple. This video is adapted from Johann Hari's New York Times best-selling book 'Chasing The Scream: The First and Last Days of the War on Drugs.' For more information, and to take a quiz to see what you know about addiction, go to www.chasingthescream.com Support us on Patreon so we can make more stuff: https://www.patreon.com/Kurzgesagt?ty=h Get the music of the video here: https://soundcloud.com/epicmountain/addiction https://epicmountainmusic.bandcamp.com/track/addiction An interactive version of this video: http://www.addiction.mobydigg.de (works on mobile) Or follow us on social media or reddit: http://kurzgesagt.org https://www.reddit.com/r/kurzgesagt https://www.facebook.com/Kurzgesagt https://twitter.com/Kurz_Gesagt THANKS A LOT TO OUR LOVELY PATRONS FOR SUPPORTING US: T0T0S, Ryan OHoro, Matthieu de Canteloube, Vince, Thomas Shiels, Brian David Henderson, Jim Yang, Arnav Guleria, Clemens, Tahseen Mushtaque, Jochen, Vahur S, Harry, BurmansHealthShop, Nils Caspar, Holger Fassel, Jackson R Hanna, Pascal de Reuck, ByeongWook Lee, Guus Ketelings, Franko Papić, Thalia, Narat, Suchartsunthorn, Lorenz Zahn, Brian Aparicio, Jörg Vogelsang, Rashed Ali, Darwin Ranzone, Tyler Thornton, David Pfister, Han Saini, Ute Moll, Ioanna Bischinioti, Jenny Zhou, Vince Babbra. Avi Yashchin, Dan Cortes, Matt K, Phiroze Dalal, Marcelo Fernandes de Souza Filho, A La Mode, Tom Wardrop, Shawn Marincas, Pontus Attåsen, Paul, Marc Dumont, Robert McKone, Todd Binkley, Matthew von der Ahe, Thomas Russell, Erick, Vivek Kotecha, Artur Szczypta, Jeff Fellows, Daniel Duffee, Konstantin Shabashov, Tim drake, Mike Galles, Evgenia Yigitalieva, Vrm Vee Are Em, Timothy Noble Everything We Think We Know About Addiction Is Wrong Help us caption & translate this video! http://www.youtube.com/timedtext_cs_panel?c=UCsXVk37bltHxD1rDPwtNM8Q&tab=2
Просмотров: 18646208 Kurzgesagt – In a Nutshell
US Anthrax Drugs
 
01:40
Washington, DC Oct. 26, 2001 APTN 1. ws executives coming to microphone 2. cutaway press 3. SOUNDBITE: Chief Operating Officer of GlaxoSmithKline, Bob Ingram, "We have committed that we will work closely with the Food and Drug Administration to expedite the approval for the use of two of our antibiotics, Augmentin and Amoxil against the anthrax strain, and if those are approved we will then donate those free of charge to anyone infected or exposed to anthrax. Secondly, we've sent in our proposal yesterday to commit to supply smallpox vaccine within that one year period we've condensint I hope everyone understands from five to one eight years down to one as several other companies are committing to." 4. ws press 5. SOUNDBITE: Peter Goland, CEO Bristol-Meyers Squibb, "In my company's case, Briston Myers Squibb, we're offering to make our antibiotic available, Tequin, assuming it's approved for the anthrax indication, at no cost to anyone who contracts that illness. Secondly, we're offering 20 to 25 scientists who have experience in antibacterial in voroligy who can work as part of a bioterrorism team to address the country's threats and needs at this time." 6. cutaway press 7. ws executives walking away STORYLINE: Leaders of major pharmaceutical companies detailed steps the companies have taken since September 11 to assist the government's efforts to protect the public health, including providing the public with free anthrax drugs which are alternatives to Cipro. The Pharmaceutical Research and Manufacturers of America (PhRMA) said the companies are coordinating their efforts as part of a newly-created Task Force on Emergency Preparedness. Pharmaceutical companies outlined a wide-range of efforts they are working on to meet new threats at a meeting with Health and Human Services Secretary Tommy Thompson in Washington Friday. Initiatives include offers of free antibiotics to authorities to treat people infected by or exposed to anthrax; offers to develop and manufacture a smallpox vaccine; pledges to increase production of certain medicines as needed; giving government scientists access to company laboratories and production facilities; making company scientists available to work in government facilities as needed. The PhRMA represents the country's leading research-based pharmaceutical and biotechnology companies. The companies are offering an alternative to Cipro, the most popular anthrax drug on the market. The patent-holding maker of Cipro, Bayer Corp., has been ramping up retail production to 100 million tablets by mid-January, according to company officials. That is in addition to the 100 million pills the company agreed to supply to the U.S. government for emergency use at a cost of 95 cents apiece. The government is stockpiling Cipro for use where it is most needed in a national emergency. A jump of nearly 50 percent in prescriptions nationwide for Cipro shows that many doctors and patients are shrugging off government pleas against stockpiling for personal use, medical and industry experts say. In the New York City area, prescriptions nearly tripled, drug marketing data indicate. Spurred by news reports on potential bioterrorism, sales of the antibiotic began climbing right after the Sept. 11 air attacks and weeks before the first news of an anthrax case on Oct. 4, according to a national marketing consultant that surveys pharmaceutical retailers. The numbers are apt to rise more still as they are released in coming weeks, because the latest data go only as far as Oct. 12 - before the last anthrax deaths and widespread Cipro treatment for postal workers. Increases were especially heavy in Washington too, which together with New York suffered the brunt of the Sept. 11 attacks. You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/a50f91724d04280e039ad4aea9dbc2cc Find out more about AP Archive: http://www.aparchive.com/HowWeWork
Просмотров: 123 AP Archive
How much does it cost to develop a new drug?
 
02:27
Pharmaceutical companies and civil society confront their calculations for the cost of a new drug. Footage: Anne Vigna Edition: Miguel Angel Gavilanes Medicamentalia 2015
Просмотров: 249 Fundación Civio
Johnson & Johnson Pharma Division Provides Earnings Bright Spot
 
00:51
Johnson and Johnson (JNJ) posted earnings on Tuesday that topped Wall Street estimates. The health and personal care giant faced currency headwinds due to the strong dollar but has increased its outlook for 2015, boosting guidance to $6.10-$6.20 per share for the year, up from $6.04-$6.19 per share. The company reported profits of $1.71 per share, up from last year's numbers and beating Wall Street estimates. Revenue was down almost 9 percent from $19.5 billion to $17.8 billion but topped estimates. The brand has topped estimates for the last 17 quarters in a run of over four years. The company's pharmaceutical division was a bright spot. Sales of its arthritis drug Simponi jumped 30 percent in the U.S. market. Johnson and Johnson also announced last month that it had received FDA approval for a new schizophrenia treatment which only needs to be administered four times a year, giving patients greater independence from their dosing. Johnson and Johnson shares have dropped almost 4 percent in the last year. Subscribe to TheStreetTV on YouTube: http://t.st/TheStreetTV For more content from TheStreet visit: http://thestreet.com Check out all our videos: http://youtube.com/user/TheStreetTV Follow TheStreet on Twitter: http://twitter.com/thestreet Like TheStreet on Facebook: http://facebook.com/TheStreet Follow TheStreet on LinkedIn: http://linkedin.com/company/theStreet Follow TheStreet on Google+: http://plus.google.com/+TheStreet
Просмотров: 190 TheStreet: Investing Strategies
Has Drugs been suppressed by the pharmaceutical companies?
 
04:25
This video gives a brief explanation of the supposed suppression of drugs by the pharmaceutical companies and explains the conspiracy behind this phenomenon.
Просмотров: 128 Sinister Conspiracies
Interview with a Business and Transformation Coach - Pharma Commercial Excellence MENA Congress
 
03:43
Samir Bata’s expertise in management, leadership, training and development has been built in 26 years in key positions in pharmaceuticals sales, marketing, national operations management and business development covering Middle East and Europe. He is a results-oriented leader who is acquainted to work with multinationals from diversified cultural backgrounds. Has a worldwide experience in training delivery and coaching many nationalities across Middle East, East Asia and Europe. He directly assessed and trained more than 25,000 people from all management and business leadership levels. During this interview, Samir Bata shares his insights about the importance of adopting an effective commercial and sales model in the pharmaceutical industry. Samir Bata is a speaker and workshop leader at the Pharma Commercial Excellence MENA Congress taking place from 16-19 February 2015 in Dubai. For more details about the congress, please visit www.mepharmaexcellence.com
Просмотров: 86 Negin Bagherian
Global Cervical Cancer Drug Industry 2015 Market Research Report
 
00:31
Big Market Research “Global Cervical Cancer Drug Industry” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast. The Global Cervical Cancer Drug Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Cervical Cancer Drug industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Cervical Cancer Drug market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. Read more details at: http://www.bigmarketresearch.com/global-cervical-cancer-drug-industry-2015-deep-research-report-market The Global Cervical Cancer Drug Industry, report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Cervical Cancer Drug industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. With 164 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Table of Contents 1 Industry Overview 1.1 Definition and Specifications of Cervical Cancer Drug 1.2 Classification of Cervical Cancer Drug 1.3 Applications of Cervical Cancer Drug 1.4 Industry Chain Structure of Cervical Cancer Drug 1.5 Industry Regional Overview of Cervical Cancer Drug 2 Manufacturing Cost Structure Analysis of Cervical Cancer Drug 2.1 Raw Material Suppliers and Price Analysis of Cervical Cancer Drug 2.2 Equipment Suppliers and Price Analysis of Cervical Cancer Drug 2.3 Labor Cost Analysis of Cervical Cancer Drug 2.4 Other Costs Analysis of Cervical Cancer Drug 3 Technical Data and Manufacturing Plants Analysis 3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014 3.2 Manufacturing Plants Distribution of Global Key Cervical Cancer Drug Manufacturers in 2014 3.3 R&D Status and Technology Source of Global Cervical Cancer Drug Key Manufacturers in 2014 3.4 Raw Materials Sources Analysis of Global Cervical Cancer Drug Key Manufacturers in 2014 4 Production Analysis of Cervical Cancer Drug by Regions, Technology, and Applications 4.1 Global Production of Cervical Cancer Drug by Regions (US, EU, China, Japan, etc.) 2010-2015 4.2 Global Production of Cervical Cancer Drug by Technology 2010-2015 4.3 Global Production of Cervical Cancer Drug by Applications 2010-2015 4.4 Price Analysis of Global Cervical Cancer Drug Key Manufacturers in 2015 5 Sales and Revenue Analysis of Cervical Cancer Drug by Regions 5.1 Global Sales of Cervical Cancer Drug by Regions (US, EU, China, Japan, etc.) 2010-2015 5.2 Global Revenue of Cervical Cancer Drug by Regions (US, EU, China, Japan, etc.) 2010-2015 5.3 Global Price Analysis of Cervical Cancer Drug Sales by Regions (US, EU, China, Japan, etc.) 2010-2015 5.4 Global Price, Cost and Gross of Cervical Cancer Drug 2010-2015 6 Analysis of Cervical Cancer Drug Production, Supply, Sales and Market Status 2010-2015 6.1 Capacity and Production of Cervical Cancer Drug 2010-2015 6.2 Production Market Share Analysis of Cervical Cancer Drug 2010-2015 6.3 Sales Overview of Cervical Cancer Drug 2010-2015 6.4 Supply, Sales and Shortage of Cervical Cancer Drug 2010-2015 Enquire about report: http://www.bigmarketresearch.com/report-enquiry/300004
Просмотров: 44 Moira Warren
Bernie Sanders' Thoughts on Drug Company Fraud and High Cost of Medicine in America
 
07:13
On May 23, 2012, Senator Bernie Sanders criticized the exorbitant prices Americans pay for prescription drugs and the enormous amount of fraud that takes place within the pharmaceutical industry. Link: http://www.sanders.senate.gov/newsroom/press-releases/sanders-crack-down-on-pharmaceutical-fraud Abbott Labs, which agreed last month to pay $1.6 billion for illegally marketing the anti-seizure drug Depakote. The New York Times said the company also agreed to plead guilty to one misdemeanor charge for violating the Food, Drug and Cosmetic Act for misbranding. Abbott Labs agreed to pay $421 million in 2010, along with two smaller companies, to settle charges that they deliberately spiked drug costs by up to 10 times the actual cost in order to boost reimbursements from Medicare and Medicaid. Pfizer, which paid $49 million to settle charges that a subsidiary defrauded the Medicaid program by overcharging for the cholesterol-lowering drug Lipitor. A division of Pfizer pleaded guilty to two felonies and agreed to pay $430 million to settle charges that it fraudulently promoted the drug Neurontin for a string of unapproved uses. GlaxoSmithKline, which in 2011 reached an "agreement in principle" to pay $3 billion to conclude the company's most significant ongoing federal government investigations into illegal sales and marketing practices for a diabetes drug that was severely restricted last year after it was linked to heart risks. Merck, which in 2009 reached a $670 million settlement for fraud on patients and Medicare/Medicaid involving a conspiracy with hospitals to give the elderly cheaper drugs but charging them for the more expensive product prescribed by the patients' doctors. Merck last year pleaded guilty to a criminal misdemeanor charge and paid a $950 million settlement for illegally promoting Vioxx for rheumatoid arthritis before that use was approved. Vioxx was linked to thousands of heart attacks and sudden cardiac deaths before it was pulled from the market in 2004. Johnson & Johnson last year illegally marketed Risperdal, an anti-psychotic medication, to nursing home patients, and paid over $2 billion in fines, a mere 6.3 percent of sales from the drug. www.ouramazingworld.org FB.com/ouramazingworldd Twitter.com/OAWoww
Просмотров: 1725 Our Amazing World
How Drug Companies Mislead Doctors and Harm Patients (2013)
 
01:26:47
Ben Michael Goldacre (born 1974) is a British physician, academic and science writer. As of 2014 he is a Wellcome research fellow in epidemiology at the London School of Hygiene and Tropical Medicine. He is a founder of the AllTrials campaign to require open science practices in clinical trials. Goldacre is known in particular for his "Bad Science" column in The Guardian, which he wrote between 2003 and 2011, and is the author of three books, Bad Science (2008), a critique of irrationality and certain forms of alternative medicine, and Bad Pharma (2012), an examination of the pharmaceutical industry, its publishing and marketing practices, and its relationship with the medical profession,[3] along with I Think You'll Find It's a Bit More Complicated Than That, a collection of his journalism. Goldacre frequently delivers free talks about bad science—he describes himself as a "nerd evangelist."[2] His second book, Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients, was published in the UK in September 2012 and in the United States and Canada in February 2013.[46] In the book he argues that: Drugs are tested by the people who manufacture them, in poorly designed trials, on hopelessly small numbers of weird, unrepresentative patients, and analysed using techniques which are flawed by design, in such a way that they exaggerate the benefits of treatments. Unsurprisingly, these trials tend to produce results that favour the manufacturer. When trials throw up results that companies don't like, they are perfectly entitled to hide them from doctors and patients, so we only ever see a distorted picture of any drug's true effects. Regulators see most of the trial data, but only from early on in a drug's life, and even then they don't give this data to doctors or patients, or even to other parts of government. This distorted evidence is then communicated and applied in a distorted fashion. In their forty years of practice after leaving medical school, doctors hear about what works through ad hoc oral traditions, from sales reps, colleagues or journals. But those colleagues can be in the pay of drug companies – often undisclosed – and the journals are too. And so are the patient groups. And finally, academic papers, which everyone thinks of as objective, are often covertly planned and written by people who work directly for the companies, without disclosure. Goldacre also contributed to The Atheist's Guide to Christmas (2009), a charity book featuring essays and anecdotes from 42 well-known atheists and apatheists, on the subject of "the power of ideas".[48] Goldacre describes himself as an apatheist.[49] He also wrote the foreword to the reprint edition of Testing Treatments: Better Research for Better Healthcare by Imogen Evans, Hazel Thornton, Iain Chalmers and Paul Glasziou, published by Pinter & Martin in March 2010. He has had several articles published in the British Medical Journal (BMJ) on the MMR vaccine,[50] science journalism,[51][52] and related topics.[53][54] In June 2012, he collaborated with the Behavioural Insights Team of the UK government on a policy paper on the use of randomised controlled trials,[55] and in May 2013, he wrote the foreword to the 'Official Guidebook' of the Romney, Hythe and Dymchurch Railway.[56] In March 2014, he worked on a systematic review of the side effects of statins compared with placebos, published in the European Journal of Preventive Cardiology.[57] Although many newspapers that covered the review said that it found that statins have "virtually no side effects",[58] Goldacre criticized this coverage as inaccurate. For example, he noted that the study relied on data from trial reports, which are likely to be incomplete. Several of Goldacre's articles were assembled into the October 2014 release I Think You'll Find It's a Bit More Complicated Than That. http://en.wikipedia.org/wiki/Ben_Goldacre
Просмотров: 4657 Way Back
Pharmaceutical Company Cuts Outlook Due to Patent Expirations and Strong Dollar
 
00:48
Pfizer's (PFE) new drugs pipeline gave their first quarter earnings a boost on Tuesday. The company beat estimates posting profits of $2.4B or $0.51 per share. Revenue was down on last year's numbers, coming in at $10.86 billion. The pharmaceuticals giant was hurt by the strong dollar and a wave of patent expirations. Pfizer cut its full year outlook for 2015 and lowered revenue forecasts to to $46.5 billion. The company saw a 44% increase in global vaccine revenue and agreed to buy injectable drugs maker Hospira for $16 billion back in February. Pfizer stock is up around 11 percent this year. Subscribe to TheStreetTV on YouTube: http://t.st/TheStreetTV For more content from TheStreet visit: http://thestreet.com Check out all our videos: http://youtube.com/user/TheStreetTV Follow TheStreet on Twitter: http://twitter.com/thestreet Like TheStreet on Facebook: http://facebook.com/TheStreet Follow TheStreet on LinkedIn: http://linkedin.com/company/theStreet Follow TheStreet on Google+: http://plus.google.com/+TheStreet
Просмотров: 92 TheStreet: Investing Strategies
TPP’s Biggest Winner: Big Pharma - The Ring Of Fire
 
10:46
Now that Fast Track has passed the hurdles of Congress, President Obama is absolutely giddy with excitement that his TPP trade deal might finally be happening. The best economists tell us that we’ll lose more jobs from this deal than we did from NAFTA and CAFTA, but that hasn’t stopped the President from telling us that this is the most progressive trade deal in history. The little information that has been leaked about the TPP tells us that the only groups to benefit will be corporations, specifically the drug industry. America’s Lawyer, Mike Papantonio, and attorney Howard Nations talk about that. Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content! Listen to Ring of Fire on Saturdays from 3pm - 6pm Eastern! Listen live via the Progressive Voices Channel on TuneIn: http://tunein.com/radio/Progressive-Voices-s189055/ Or find a station here: http://www.ringoffireradio.com/station/ Watch Ring of Fire every weekday at 8:30pm EST on Free Speech TV! Support Ring of Fire by subscribing to our YouTube channel: http://www.youtube.com/user/golefttv You can also support us here: http://www.ringoffireradio.com/support/ Your continued support keeps Ring of Fire on the air! Follow more of our stories at http://www.RingofFireRadio.com Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Support us further by shopping on Amazon via our Amazon-Ring of Fire partnership link. A portion of the sales will come back to Ring of Fire at no extra cost to you. Bookmark and follow the link below and continue shopping as usual! Amazon - Ring of Fire partnership link: http://www.amazon.com/?tag=rinoffir-20
Просмотров: 900 The Ring of Fire
Hold IPCA Laboratories, says Mayuresh Joshi
 
02:47
Mayuresh Joshi says that If one looks at the import ban and the statistics involved with the US sales for Ipca Laboratories, FY14 as a perspective, they contributed around Rs 414 odd crore which is 12 percent of the total sales, 20 percent of their exports and if I distinguish between domestic and EPI – its around 61:39 ration. Having said that, couple of their molecules from the Ratlam facility has not been affected by the ban and they probably account around 45 percent of the US sales. Investors should hold on to the stock. We are very optimistic on the stock from FY17 perspective.
Просмотров: 507 Angel Broking
Why is College So Expensive?
 
04:54
College is a good deal, but it could be a much better deal. A combination of factors have driven the costs of higher education in America to increase extremely quickly, pricing some people out of an education and building over a trillion dollars in student loan debt. So why? Why did those costs increase and what are schools spending all that fat cash on. Turns out, it's pretty complicated. Can you lower your student loans? http://www.vox.com/2014/10/1/6050243/student-loan-repayment-options SOURCES Trends in College Spending: 1998 to 2008 http://www.deltacostproject.org/sites/default/files/products/Trends-in-College-Spending-98-08.pdf Trends in College Spending 2001 to 2011: http://www.deltacostproject.org/sites/default/files/products/Delta%20Cost_Trends%20College%20Spending%202001-2011_071414_rev.pdf Vox.com - Everything you need to know about Student Debt: http://www.vox.com/cards/student-debt/what-is-a-student-loan Vox.com - Everything you need to know about college costs: http://www.vox.com/cards/college-costs/what-is-college Is Starting College and Not Finishing That Bad? http://www.hamiltonproject.org/papers/what_happens_to_students_who_fail_to_complete_a_college_degree_is_some/ Public Colleges Revenue Shift: https://www.insidehighered.com/news/2015/04/13/report-shows-public-higher-educations-reliance-tuition\ Tuition Fees and Room and Board over time: http://trends.collegeboard.org/college-pricing/figures-tables/tuition-fees-room-board-time Hiring Spree Fattens College Bureaucracy: http://www.wsj.com/articles/SB10001424127887323316804578161490716042814 Problematic Boom in Higher Education Administrators: http://www.huffingtonpost.com/2014/02/06/higher-ed-administrators-growth_n_4738584.html ---- Subscribe to our newsletter! http://nerdfighteria.com/newsletter/ And join the community at http://nerdfighteria.com http://effyeahnerdfighters.com Help transcribe videos - http://nerdfighteria.info John's twitter - http://twitter.com/johngreen John's tumblr - http://fishingboatproceeds.tumblr.com Hank's twitter - http://twitter.com/hankgreen Hank's tumblr - http://edwardspoonhands.tumblr.com
Просмотров: 907132 vlogbrothers
A country for sociopaths by sociopaths
 
09:01
Thank you everyone on Patreon for another amazing month of support https://www.patreon.com/h3h3productions
Просмотров: 3116050 Ethan and Hila
Wedding attracts foreign visitors in large numbers
 
03:03
(26 Apr 2011) SHOTLIST 1. Tower of London with tour boat sailing past on river in foreground 2. Tower of London walls and buildings 3. Tourists clambering down stairs on Tower of London rampart 4. Reverse shot of group of American tourists, all dressed identically in red outfits and hats with American flags, looking at Tower of London 5. Front view of Americans standing in line 6. Tourists displaying hands all with identical rings, copies of Kate Middleton's engagement ring 7. SOUNDBITE: (English) Marcia Anderson, 49-year-old pharmaceutical sales representative from Oklahoma City, United States: "London's just a great city. Great history - obviously the Tower and everything here. But then to have the royals and to be able to come and see all the royal things...." SOUNDBITE: (English) Mary Boepple, 49-year-old retiree from Cyprus, Texas, United States - and twin sister of Marcia Anderson: "The thousands of years of history is what's exciting and walking in their (the royal family's) footsteps and enjoy the places that we know that they've been." 8. Tourists walking along Tower of London concourse 9. Tourist taking photograph 10. Tourists walking along walls of Tower of London 11. SOUNDBITE: (English) John Keohane, Chief Yeoman Warder of the Tower of London: "There's so much tradition and this is what I think - especially our visitors from the United States or (elsewhere) abroad - come here to see. They want to come and see all what the British monarchy is all about and why it's so important to all of us that live here in this great country." 12. Group of German tourists looking at guide book 13. Tourists' hands and guide book 14. SOUNDBITE: (German) Jonathan Soenenan, 30 year-old tourist from Berlin, Germany: "We hadn't planned to come here for the royal wedding and it's a coincidence that it's happening while we're here. There's lots going on that we didn't expect, but I might go down on the day and wave at the royal couple!" 15. Tourists walking along concourse 16. SOUNDBITE: (Italian) Massimo Caneva, tourist from Treviso, Italy: "It's fun for the children, especially to see the crown jewels, as well as other things connected to queens and kings, and so they're having a great time." 17. Caneva and family walking away from camera 18. Long shot of Tower of London concourse with tourists walking 19. Tourist taking photograph next to river with Tower of London in background - pans right to show group posing for photograph in front of Tower Bridge 20. Tourists with camera looking at river 21. SOUNDBITE: (English) Jacqueline French, spokesperson for London and Partners, the official promotional agency for London: "What we are hoping is that the royal wedding will really put a spotlight on London. There's an approximate four (b) billion people will be watching the wedding overseas. We've got the queen's jubilee next year, as well as the 2012 Olympic and Paralympic Games. And all of this will create a sense of fun and great atmosphere in London that hopefully people will want to be a part of." 22. Group of tourists by river with map and camera 23. Wide shot of Tower Bridge and River Thames with tourists walking STORYLINE: The British capital is witnessing a boom in tourism ahead of Friday's royal wedding. Some London landmarks are reporting swelling numbers of international visitors, many of whom say they're here primarily because of Prince William and Kate Middleton's 29 April nuptials. Tourists were flocking to the Tower of London on Tuesday. The iconic landmark by the River Thames, with its 900 years of royal history, is a regular stop on the tourist trail. But numbers are definitely up, according to officials. They wore matching red hats, complete with American flags, and identical red outfits. You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/140aeab52eef79898706b0d8f244b330 Find out more about AP Archive: http://www.aparchive.com/HowWeWork
Просмотров: 39 AP Archive
► China industrial production still sluggish
 
01:03
China's industrial output in November grew more than 6 percent from a year earlier. But the figure remains lower than last year's level. Officials at the National Bureau of Statistics say the year-on-year growth of industrial output came to 6.2 percent, up 0.6 percentage points from the previous month. The increase came as government stimulus measures boosted auto production. But the growth was below the level of various industries in 2014 which mostly marked more than 7 percent. That was another sign the world's second largest economy has stalled. Real-estate investment was sluggish. Production of crude steel and cement was also down from the same month last year. These apparently outweighed the double-digit surge in retail sales of 11.2 percent year-on-year, up 0.2 percentage points from October. Besides auto dealers, online shopping sites did well. Analysts say lackluster earnings of manufacturers and other firms are casting a shadow over China's economic outlook, putting a damper on overall consumption.
Просмотров: 260 Best News Of World
AppExchange for Life Sciences: Where Cloud Meets Compliance
 
38:30
The Life Sciences industry has unique needs and requirements, from Global Regulatory Compliance to Clinical Trial Management, from Quality Manufacturing to Device Tracking, and more! Join us to learn why partners are choosing the Salesforce1 platform to develop apps for Life Sciences and how customers are succeeding using those apps. We'll share apps that have been built specifically to address the needs of medical devices and pharmaceutical organizations, as well as apps that make your users more productive. You'll walk away with real-world knowledge of how to further your investments in Salesforce technologies.
Просмотров: 529 Dreamforce Video
How Big Oil Conquered the World
 
01:11:27
TRANSCRIPT AND SOURCES: https://www.corbettreport.com/?p=16888 From farm to pharmaceutical, diesel truck to dinner plate, pipeline to plastic product, it is impossible to think of an area of our modern-day lives that is not affected by the oil industry. The story of oil is the story of the modern world. And this is the story of those who helped shape that world, and how the oil-igarchy they created is on the verge of monopolizing life itself.
Просмотров: 1280484 corbettreport
Statistical Analysis and Interpretation Why it is important for a Master's Student
 
00:46
http://www.statswork.com/ . Statswork has been established with an outlook to provide high quality statistical and biostatistical services to a wide range of industry sectors that includes: Corporate Academic FMCG Logistics R & D Pharmaceutical and Banking Based on our vast experience spanning over 15 years, we have been able to deliver services that are accurate, concise and extremely intrinsic to overall business and academic objectives. Our highly qualified personnel, trained from reputed international universities like Harvard are well experienced in supporting clients with the requisite skills and know-how to execute complex statistical / biostatistical analysis and research activities. Our repertoire for servicing fortune 500 companies has propelled us to the forefront, thereby emerging as a trusted name in the field of statistical and biostatistical analytics.
Просмотров: 491 Stats Work
China Monoclonal Antibodies Industry 2015 Market Research Report
 
00:31
Big Market Research “China Monoclonal Antibodies Industry” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast. The China Monoclonal Antibodies Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Monoclonal Antibodies industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Monoclonal Antibodies market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. Read more details at: http://www.bigmarketresearch.com/china-monoclonal-antibodies-industry-2015-deep-research-report-market The China Monoclonal Antibodies Industry, report focuses on China major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Monoclonal Antibodies industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. With 150 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Table of Contents Chapter One Industry Overview 1.1 Definition and Specifications of Monoclonal Antibodies 1.2 Classification of Monoclonal Antibodies 1.3 Applications of Monoclonal Antibodies 1.4 Industry Chain Structure of Monoclonal Antibodies Chapter Two Manufacturing Cost Structure Analysis of Monoclonal Antibodies 2.1 Bill of Materials (BOM) of Monoclonal Antibodies 2.2 BOM Price Analysis of Monoclonal Antibodies 2.3 Labor Cost Analysis of Monoclonal Antibodies 2.4 Depreciation Cost Analysis of Monoclonal Antibodies Chapter Three Technical Data and Manufacturing Plants Analysis 3.1 Capacity and Commercial Production Date of China Key Manufacturers in 2014 3.2 Manufacturing Plants Distribution of China Key Monoclonal Antibodies Manufacturers in 2014 3.3 R&D Status and Technology Source of China Monoclonal Antibodies Key Manufacturers in 2014 3.4 Raw Materials Sources Analysis of China Monoclonal Antibodies Key Manufacturers in 2014 Chapter Four Production Analysis of Monoclonal Antibodies by Regions, Technology, and Applications 4.1 China Production of Monoclonal Antibodies by Regions (Key Provinces) 2010-2015 4.2 China Production of Monoclonal Antibodies by Product Types 2010-2015 4.3 China Sales of Monoclonal Antibodies by Applications 2010-2015 4.4 Price Analysis of China Monoclonal Antibodies Key Manufacturers in 2015 Chapter Five Sales and Revenue Analysis of Monoclonal Antibodies by Regions 5.1 China Sales of Monoclonal Antibodies by Regions 2010-2015 5.2 China Revenue of Monoclonal Antibodies by Regions 2010-2015 5.3 China Price Analysis of Monoclonal Antibodies Sales by Regions 2010-2015 5.4 China Price, Cost and Gross of Monoclonal Antibodies 2010-2015 Chapter Six Analysis of Monoclonal Antibodies Production, Supply, Sales and Market Status 2010-2015 6.1 Capacity Production Sales Revenue of Monoclonal Antibodies 2010-2015 6.2 Production Sales Market Share Analysis of Monoclonal Antibodies 2014-2015 6.3 Import, Export and Consumption of Monoclonal Antibodies 2010-2015 6.4 Supply, Consumption and Shortage of Monoclonal Antibodies 2010-2015 Enquire about report: http://www.bigmarketresearch.com/report-enquiry/300090
Просмотров: 132 Leona Rich
Why Symphony? | Symphony Health Solutions
 
04:34
Symphony Health Solutions provides thorough data and powerful analytics to help professionals understand the full market lifecycle, from predictive market analysis to patient influence, physician prescribing, pharmacy fulfillment, payer reimbursement, and sales compensation. --- At Symphony Health Solutions, we provide powerful data, applications, analytics, and consulting to help companies gain deep insight into the pharmaceutical market. Significant changes are radically reshaping the healthcare market, and our services provide a comprehensive, leading-edge perspective on the real dynamics that can make or break the success of brands. http://symphonyhealth.com/ Connect with Us! Twitter | http://bit.ly/1MCevz0 LinkedIn | http://bit.ly/1NvbdT8
Просмотров: 604 Symphony Health Solutions
Antidepressant Market in the US 2015 2019
 
00:56
Antidepressant Market in the US 2015 2019 http://www.marketresearchstore.com/report/antidepressant-market-in-the-us-2015-2019-4322 According to the WHO, depression is a common mental disorder which contributes significantly to the global burden of disease. It affects people across communities in the world. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration, as stated by the WHO. Depression can roughly be categorized into six different types. A patient with severe depression can have suicidal thoughts or behaviors. According to a 2012 WHO estimate, approximately 3,000 suicides take place each day, resulting in more than a million deaths per annum. Table of Content 1. Executive Summary 2. List of Abbreviations 3. Scope of the Report 3.1 Market Overview 3.2 Product Offerings 4. Product Profiles 4.1.1 Celexa 4.1.2 Fetzima 4.1.3 Lexapro 4.1.4 Viibryd 4.1.5 Cymbalta 4.1.6 Prozac 4.1.7 Symbyax 4.1.8 Paxil 4.1.9 Wellbutrin 4.1.1 Abilify 4.1.11 Effexor 4.1.12 Pristiq 4.1.13 Zoloft 5. Market Research Methodology 5.1 Market Research Process 5.2 Research Methodology 6. Introduction 7. Disorder Overview 7.1 Depression & its Types 7.1.1 Major Depressive Disorder 7.1.2 Persistent Depressive Disorder 7.1.3 Psychotic Depression 7.1.4 Post-partum Depression 7.1.5 Seasonal Affective Disorder 7.1.6 Bipolar Disorder 7.2 Etiology 7.3 Epidemiology 7.3.1 Bipolar Disorder Among Adults 7.3.2 Dysthymic Disorder Among Adults 7.3.3 Major Depression Among Adults 7.3.4 Major Depression Among Adolescents 7.4 Treatment & Management 7.5 Economic Burden 8. Market Landscape 8.1 Market Overview 8.2 Market Size and Forecast 8.3 Five Forces Analysis 9. Market Segmentation by Mechanism of Action 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Trends and their Impact 17. Vendor Landscape 17.1 Competitive Scenario 17.1.1 Key News 17.1.2 Mergers and Acquisitions 17.2 Market Share Analysis 2014 17.2.1 Competitive Assessment of the Top Drugs for Depression 17.2.2 Eli Lilly 17.2.3 Otsuka Pharmaceutical 17.2.4 Pfizer 17.2.5 GlaxoSmithKline 17.2.6 Actavis 17.3 Other Prominent Vendors 18. Key Vendor Analysis 18.1 Actavis 18.1.1 Key Facts 18.1.2 Business Description 18.1.3 Business Segmentation 18.1.4 Business Segmentation by Revenue 2012 and 2013 18.1.5 Sales by Geography 18.1.6 Business Strategy 18.1.7 Key Information 18.1.8 SWOT Analysis 18.2 Eli Lilly 18.2.1 Key Facts 18.2.2 Business Overview 18.2.3 Business Segmentation by Revenue 18.2.4 Sales by Geography 18.2.5 Business Strategy 18.2.6 Key Information 18.2.7 SWOT Analysis 18.3 GlaxoSmithKline 18.3.1 Key Facts 18.3.2 Business Overview 18.3.3 Business Segmentation 18.3.4 Business Segmentation by Revenue 2012 and 2013 18.3.5 Sales by Geography 18.3.6 Pipeline Products 18.3.7 Business Strategy 18.3.8 Key Information 18.3.9 SWOT Analysis 18.4 Otsuka Pharmaceutical 18.4.1 Key Facts 18.4.2 Business Overview 18.4.3 Business Segmentation by Revenue 2014 18.4.4 Business Segmentation by Revenue 2013 and 2014 18.4.5 Geographical Segmentation by Revenue 2014 18.4.6 Business Strategy 18.4.7 Recent Developments 18.4.8 SWOT Analysis 18.5 Pfizer 18.5.1 Key Facts 18.5.2 Business Overview 18.5.3 Business Segmentation by Revenue 2013 18.5.4 Business Segmentation by Revenue 2012 and 2013 18.5.5 Geographical Segmentation by Revenue 18.5.6 Business Strategy 18.5.7 Key Developments 18.5.8 SWOT Analysis
Просмотров: 154 Market Research Store
Top 41 interview questions and answers
 
01:09:44
Top 41 interview questions and answers. Job interview tips to answer toughest interview questions, how to prepare for job interviews. Our useful video list for your job interview: 1. Top 15 job interview tips: https://www.youtube.com/watch?v=Zy1oNk616_U 2. 12 types of interview questions and how to face them: https://www.youtube.com/watch?v=HvdjRZHeaOo 3. Top 14 common mistakes in job interviews: https://www.youtube.com/watch?v=S3l7COBI77U To watch each question, please click the time below: (00:10) Question 1. Can you tell me a little about yourself (03:09) Question 2. Why are you leaving your last job (05:11) Question 3 What is your greatest weakness (07:53) Question 4 What is your greatest strength (10:01) Question 5 Where do you see yourself being in 3-5 years from now (13:05) Question 6 Why should we hire you (15:03) Question 7 What do you know about this organization (17:03) Question 8 Why do you want this job (19:41) Question 9 Let's talk about salary. What are you looking for (24:14) Question 10. Do you have any questions for us (27:50) Question 11. Are you a team player (29:49) Question 12. What is the biggest mistake you have ever made (31:09) Question 13. Why is there a gap in your work history (33:10) Question 14. Tell me about a problem you have solved (34:15) Question 15. What do you dislike about your last job (35:03) Question 16. What has been your greatest achievement (36:29) Question 17. Tell me about any issues you've had with a previous boss (37:55) Question 18. Tell me a suggestion you have made that was implemented (39:16) Question 19. Would you rather work for money or job satisfaction (40:12) Question 20. Has anything ever irritated you about people you've worked with (1) (40:47) Question 21. What relevant experience do you have (42:15) Question 22. How are you when you're working under pressure (43:51) Question 23. What is your biggest failure (45:31) Question 24. How would your boss, supervisors and co-workers describe you (47:09) Question 25. What sort of person do you not like to work with (48:56) Question 26. What have you done to improve your skills, knowledge in the last year (50:23) Question 27. Tell me about a challenge or conflict you've faced at work, and how you dealt with it (52:31) Question 28. Do you know anyone that works with our company (53:04) Question 29. How long do you want to work for us if we hire you (54:03) Question 30. Are you willing to work overtime (54:53) Question 31. What is your dream job (56:26) Question 32. Describe your work ethic (58:48) Question 33. What other companies are you interviewing with (1:00:09) Question 34. Are you willing to travel or relocated if necessary (1:01:29) Question 35. What was the most difficult decision for you to make (1:03:14) Question 36. Describe a major goal you've set for yourself recently (1:04:03) Question 37. What will you do if you don't get this job (1:05:19) Question 38. What motivates you at the workplace (1:06:40) Question 39. How do you measure success (1:07:13) Question 40. Describe your management style (1:08:35) Question 41. Technical interview questions Tag: #Top41InterviewQuestionsAndAnswers with English subtitles. Learning English by job interview questions. *Other useful materials:* + jobguide247.com/free-ebook-440-behavioral-interview-questions-and-answers + jobguide247.com/free-ebook-54-situational-interview-questions-with-answers + jobguide247.com/free-ebook-95-management-interview-questions-with-answers + jobguide247.com/free-ebook-30-phone-interview-questions-with-answers + jobguide247.com/free-ebook-290-competency-based-interview-questions-and-answers + jobguide247.com/free-ebook-45-internship-interview-questions-and-answers + jobguide247.com/free-ebook-top-free-14-cover-letter-samples + jobguide247.com/free-ebook-top-free-16-resume-sample + jobguide247.com/free-ebook-top-15-ways-to-search-new-jobs + jobguide247.com/free-ebook-145-interview-questions-and-answers-pdf-download + jobguide247.com/free-ebook-45-fresher-interview-questions-and-answers Fields related: sales, marketing, project management, purchasing, logistics, call center, customer service, finance, accounting, restaurant, hotel, production, warehouse, maintenance, maintenance, electrical, nurse, teacher, pilot, firefighter, police, flight attendant, airline, business analyst, bank, accounts payable, accounts receivable, engineering, qa, qc, pharmacy, retail ... Useful videos: + 25 most common job interview questions and how to answer them part 2 / Aw1ekqxULTs + Job Interview Question & Answers for freshers: gnqzM6FWgTE
Просмотров: 2738401 JobGuide247
High Salary Jobs in Dubai
 
03:08
High Paid jobs offered in Dubai now a days. How much pilots, bankers, doctors, engineers, managers can earn in Dubai.
Просмотров: 768233 GoAbroad
Analysis of the Expanding U.S. Market for Gastrointestinal Disorders Prescription Pharmaceuticals
 
01:13
1. Investigation of the Expanding U.S. Market for Gastrointestinal Disorders Prescription Pharmaceuticals Bowel Disorders Market is Buoyant and Poised for Growth NBB6-52 November 2012 2. ContentsSection Slide Numbers Executive Summary 14 Market Overview 20 • Definitions 21 • Overview of Inflammatory Bowel Disease 23 o Incidence and Prevalence of Inflammatory Bowel Disease 24 o Diagnosis of Inflammatory Bowel Disease 25 o Clinical Severity of Inflammatory Bowel Disease 27 o Assessment of Disease Activity in IBD Clinical Trials 29 o Anatomic Extent of Ulcerative Colitis 31 o Clinical Guidelines 33 • Overview of Irritable Bowel Syndrome 38 o Diagnosis of IBS 39 o Assessment of Disease Activity in IBS Clinical Trials 40 o Clinical Trial Design Guidance—IBS 41 o Clinical Guidelines—IBS 43 • Personalized Medicine in Bowel Disorders 44 • Key Questions This Study Will Answer 45 • Market Overview—Segmentation 46NBB6-52 3. Substance (continued)Section Slide Numbers External Challenges: Drivers and Restraints 57 Forecasts and Trends 69 Demand Analysis 84 Market Share and Competitive Analysis 87 Inflammatory Bowel Disease Prescription Pharmaceuticals Segment 123 •5-ASA Subsegment Breakdown 127 •Corticosteroid Subsegment Breakdown 138 •TNF Inhibitor Subsegment Breakdown 149 •Non-TNF Biologicals Subsegment Breakdown 160 •Novel Orals Subsegment Breakdown 169 Irritable Bowel Syndrome Prescription Pharmaceuticals Segment 177 The Last Word (Conclusions and Implications) 188 Game-changing Strategies 193 Appendix 195NBB6-52 4. Research TeamLead Analyst Contributing AnalystDeborah Toscano Jennifer BriceSenior Industry Analyst Global Program ManagerLife Sciences Life SciencesResearch Director Strategic Review Committee LeaderDaniel Ruppar Greg CaressiResearch Director Sr. Bad habit PresidentHealthcare HealthcareNBB6-52 5. Official Summary—CEO's Perspective Growth opportunity in the IBD business sector lies in 1 presentation of enhanced items, though the IBS business sector is generally undiscovered. Comfort, adequacy, security, and bearableness 2 are fundamental to the accomplishment of new treatments. More medication treatments must be created for 3 IBD patients who come up short first line treatments. Gastrointestinal inside scatters influence a 4 extensive populace over a wide demographic. Techniques to streamline tolerant adherence to 5 treatment could significantly enhance general clinical results and item achievement. Source: Frost & Sullivan analysis.NBB6-52 6. Market Overview—Segmentation Total Bowel Disorders Prescription Pharmaceuticals Market: Market Segmentation, U.S., 2011 Total Bowel Disorders Prescription Pharmaceuticals Market IBS IBD IBS-C IBS-D CD* UC* Oral or Injectable Treatments Topical Treatments***Considered by and large in forecasts** Not assessed in this exploration Source: Frost & Sullivan examination. NBB6-52 7. Market Overview—Segmentation (proceeded with) Total Bowel Disorders Prescription Pharmaceuticals Market: IBD Market Segmentation, U.S., 2011 Inflammatory Bowel Disease Prescription Pharmaceuticals Market CD UC Oral or Injectable Treatments Topical Treatments* 5-ASA Antibiotics* Corticosteroid Antimetabolite* Biologicals Novel Orals** ASA Corticosteroid TNFs Non-TNF Biologicals•Not secured in this examination service** Investigational; none yet sanction for IBD Source: Frost & Sullivan investigation. NBB6-52 8. Market Overview—Segmentation (proceeded with) Total Bowel Disorders Prescription Pharmaceuticals Market: IBS Market Segmentation, U.S., 2011 Irritable Bowel Syndrome Prescription Pharmaceuticals Market IBS-C IBS-M* IBS-D 5-HT3 (serotonin) Chloride channel (ClC-2) activator (diuretic) adversary Guanylate cyclase sort C receptor agonist*Not secured in this exploration benefit because of absence of sanction therapiesNote: Subsegmentation of the IBS business sector portion is not gave because of low level of business movement Source: Frost & Sullivan examination. NBB6-52 9. Market Overview—Segmentation (proceeded with) Total Bowel Disorders Prescription Pharmaceuticals Market: Percent Sales Breakdown by Drug Class, U.S., 2011 IBS-C Drugs, 5.5% IBS-D Drugs, 1.1% Corticosteroids, 8.6 % TNF inhibitors, 48.7% Biologicals, 49.5% 5-ASA, 35.3% Non-TNF biologicals, 0.8% Note: All figures are adjusted. The base year is 2011. Source: Frost & Sullivan analysis.NBB6-52
Просмотров: 22 DailySlides
Lupin Q4 Net Profit Slips; Slow Growth Dents Margins: Interview with CEO, Nilesh Gupta
 
13:39
Drug firm Lupin saw consolidated net profit fell 1.1 percent to Rs 547 crore in January-March quarter from Rs 553 crore in the corresponding quarter last fiscal. During the period, its revenue was alm
Просмотров: 413 CNBC-TV18
The Men Who Made Us Spend   Episode 2
 
58:36
Просмотров: 37456 Dirk Schemberg
Free Speech TV | Episode 195 - Walker Won't Be President, But Still An Asshole - The Ring Of Fire
 
28:53
Scott Walker might be out of the presidential race, but his reign of terror in Wisconsin is far from over. We’ll tell you how Walker and his fellow Republicans are trying to destroy transparency in Wisconsin… And Jeb Bush’s campaign is on the ropes, and Donald Trump is ready to deliver the final blow. Could Jeb’s political career finally be over?… Spread the word! LIKE and SHARE this stream or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content! Follow more of our stories at http://www.RingofFireRadio.com Listen to Ring of Fire on Saturdays from 3pm - 6pm Eastern! Listen live via the Progressive Voices Channel on TuneIn: http://tunein.com/radio/Progressive-Voices-s189055/ Or find a station here: http://www.ringoffireradio.com/station/ Watch Ring of Fire every weekday at 8:30pm EST on Free Speech TV! Support Ring of Fire by subscribing to our YouTube channel: http://www.youtube.com/user/golefttv You can also support us here: http://www.ringoffireradio.com/support/ Your continued support keeps Ring of Fire on the air! Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Support us further by shopping on Amazon via our Amazon-Ring of Fire partnership link. A portion of the sales will come back to Ring of Fire at no extra cost to you. Bookmark and follow the link below and continue shopping as usual! Amazon - Ring of Fire partnership link: http://www.amazon.com/?tag=rinoffir-20
Просмотров: 2390 The Ring of Fire
Construction Sales Software by Routzy
 
49:51
Be proactive. It's time to give your construction sales team the most incredible software program ever built. This amazing, spectacular iPad CRM effortlessly perfects your sales cycle. Best of all, it's completely mobile. Read more at Routzy.com. Change your company's future today. 00:00 Intro/What is Routzy? 06:13 Sales Routes 12:40 Activities 19:09 Quotes and Proposals 24:08 Drawings and Pictures 29:22 Forms 35:03 Analytics 40:11 Dropbox Integration 46:00 Support/About Us In some ways, construction sales will always be something of a numbers game. Often, making sales means approaching as many leads and prospects as humanly possible. This stands to reason. The more contacts you reach, the more deals you'll ultimately make. However, if you're only measuring success by the girth of your monthly sales total, you're stuck somewhere in the dark. It would be equally beneficial to understand how many calls or emails your reps make in a day. Figuring out which contact methods yield the best results can be crucial in improving your process. The construction sales app Routzy gives you a focused, reliable way to keep track of these things. Routzy tracks activities at whatever frequency you desire. Get hourly reports, daily reports, monthly reports, whatever you want. If there's a better way to see which methods are best in making deals, we'd like to see it. Routzy records extensive logs of all the actions its users perform. At the end of the day, Routzy's analytics help determine where the best leads originate, and which methods will help you capitalize. Learn more by accessing: http://www.routzy.com/ http://www.routzy.tv/
Просмотров: 220 RoutzyApp
Sales MBA: 4 Leadership Tactics to Be the Master of Your Sales Results
 
40:13
You have had Sales 101. Now it is time take your skills to the graduate level. Learn to implement best-in-class tactics to use Salesforce to move the needle in or your organization. This session will teach you the 4 keys to being a data-driven sales leader. You''ll learn how to move past using Salesforce as a success journal filled with lagging indicators and enter the world of predictive sales coaching and empowered leadership. See hands-on examples and take back to your company tools proven to create significant sales results. Join us for the "extended edition" of this encore session, brought back by popular demand.
Просмотров: 308 Dreamforce Video
The Republicans Debated For Five Hours And Said Absolutely Nothing - The Ring Of Fire
 
07:12
If you were unfortunate enough to sit through all five hours of Republican debating on Wednesday, you probably noticed how the candidates managed to talk about each other instead of actual issues. While the GOP continues to paint America as a ticking time bomb of doom, you really start to get the sense that these talking heads have no solutions for anything. Ring of Fire's Sam Seder and Farron Cousins discuss this. Follow more of our stories at http://www.RingofFireRadio.com Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content! Listen to Ring of Fire on Saturdays from 3pm - 6pm Eastern! Listen live via the Progressive Voices Channel on TuneIn: http://tunein.com/radio/Progressive-Voices-s189055/ Or find a station here: http://www.ringoffireradio.com/station/ Watch Ring of Fire every weekday at 8:30pm EST on Free Speech TV! Support Ring of Fire by subscribing to our YouTube channel: http://www.youtube.com/user/golefttv You can also support us here: http://www.ringoffireradio.com/support/ Your continued support keeps Ring of Fire on the air! Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Support us further by shopping on Amazon via our Amazon-Ring of Fire partnership link. A portion of the sales will come back to Ring of Fire at no extra cost to you. Bookmark and follow the link below and continue shopping as usual! Amazon - Ring of Fire partnership link: http://www.amazon.com/?tag=rinoffir-20
Просмотров: 2414 The Ring of Fire
Global Disposable Medical Gloves Industry 2015 Deep Market Research Report
 
00:31
Big Market Research “Global Disposable Medical Gloves Industry” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2020. The Global Disposable Medical Gloves Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Disposable Medical Gloves industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Disposable Medical Gloves market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. Read more details at: http://www.bigmarketresearch.com/global-disposable-medical-gloves-industry-2015-deep-research-report-market The Global Disposable Medical Gloves Industry, report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Disposable Medical Gloves industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. With 165 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Table of Contents 1 Industry Overview 1.1 Definition and Specifications of Disposable Medical Gloves 1.2 Classification of Disposable Medical Gloves 1.3 Applications of Disposable Medical Gloves 1.4 Industry Chain Structure of Disposable Medical Gloves 2 Manufacturing Cost Structure Analysis of Disposable Medical Gloves 2.1 Raw Material Suppliers and Price Analysis of Disposable Medical Gloves 2.2 Equipment Suppliers and Price Analysis of Disposable Medical Gloves 2.3 Labor Cost Analysis of Disposable Medical Gloves 2.4 Other Costs Analysis of Disposable Medical Gloves 3 Technical Data and Manufacturing Plants Analysis 3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014 3.2 Manufacturing Plants Distribution of Global Key Disposable Medical Gloves Manufacturers in 2014 3.3 R&D Status and Technology Source of Global Disposable Medical Gloves Key Manufacturers in 2014 3.4 Raw Materials Sources Analysis of Global Disposable Medical Gloves Key Manufacturers in 2014 4 Production Analysis of Disposable Medical Gloves by Regions, Technology, and Applications 4.1 Global Production of Disposable Medical Gloves by Regions (US, EU, China, Japan, etc.) 2010-2015 4.2 Global Production of Disposable Medical Gloves by Technology 2010-2015 4.3 Global Production of "& B1 &" by Applications 2010-2015 4.4 Price Analysis of Global Disposable Medical Gloves Key Manufacturers in 2015 5 Sales and Revenue Analysis of Disposable Medical Gloves by Regions 5.1 Global Sales of Disposable Medical Gloves by Regions (US, EU, China, Japan, etc.) 2010-2015 5.2 Global Revenue of Disposable Medical Gloves by Regions (US, EU, China, Japan, etc.) 2010-2015 5.3 Global Price Analysis of Disposable Medical Gloves Sales by Regions (US, EU, China, Japan, etc.) 2010-2015 5.4 Global Price, Cost and Gross of Disposable Medical Gloves 2010-2015 6 Analysis of Disposable Medical Gloves Production, Supply, Sales and Market Status 2010-2015 6.1 Capacity and Production of Disposable Medical Gloves 2010-2015 6.2 Production Market Share Analysis of Disposable Medical Gloves 2010-2015 6.3 Sales Overview of Disposable Medical Gloves 2010-2015 6.4 Supply, Sales and Shortage of Disposable Medical Gloves 2010-2015 Enquire About Report: http://www.bigmarketresearch.com/report-enquiry/300690
Просмотров: 157 Melvin Wells
FDA Gives Pfizer Nod for Breast Cancer Drug Two Months Early
 
02:55
Disney, Macy's and Green Mountain Coffee Roasters are in focus in earnings news and Pfizer gets the greenlight from the FDA for a breast cancer drug two months early. Disney posted better than expected earnings and higher revenue in its latest quarter thanks to strong topline numbers from its TV networks and sales of paraphernalia associated with the animated movie Frozen. Macy's is a stock to watch today as it raised its outlook for the year and plans to buy BlueMercury for $210 million in cash. The FDA has granted early approval of Pfizer's drug used to treat advanced stage breast cancer. The approval of Inbrance came two months early. Pfizer needs some big-selling new drugs to boost its earnings, following patent expirations on many of its biggest brands and a relatively thin supply of promising drugs in late-stage trials. Pfizer said the drug is available to order immediately through specialty pharmacies. Keurig Green Mountain Coffee Roasters turns in first quarter earnings results today. KeyBank Capital Markets reiterates its BUY rating on GMCR with a $175 price target. Sales of single K Cups versus sales of brewers are expected to drive numbers. Subscribe to TheStreetTV on YouTube: http://t.st/TheStreetTV For more content from TheStreet visit: http://thestreet.com Check out all our videos: http://youtube.com/user/TheStreetTV Follow TheStreet on Twitter: http://twitter.com/thestreet Like TheStreet on Facebook: http://facebook.com/TheStreet Follow TheStreet on LinkedIn: http://linkedin.com/company/theStreet Follow TheStreet on Google+: http://plus.google.com/+TheStreet
Просмотров: 162 TheStreet: Investing Strategies
Wyden & Grassley Sovaldi Investigation Press Conference
 
23:13
U.S. Senators Ron Wyden, D-Ore., and Chuck Grassley, R-Iowa, discuss findings of investigation into pricing of Sovaldi. In 2014, Medicaid programs spent $1 billion on Gilead’s Hepatitis C drugs, yet more than 97% of Medicaid patients went untreated.
Просмотров: 2631 Ron Wyden
[439] VW scandal spreads to Europe, Asia
 
27:50
It seems the fallout for Volkswagen is just getting larger – by 11 million diesel cars! Ameera David weighs in. Then, Ameera is joined by Edward Harrison in Greece to get the latest on the migrant crisis and reaction to the election. After the break, Bianca Facchinei takes a look at new – and disappointing – study on affordable housing the in US. Then, Erin Ade sits down with Lenore Hawkins – founding partner of Meritas Advisors – to talk about the Fed. And in The Big Deal, Ameera and Erin discuss how a new pharmaceutical company increased the price of a drug by over 5,000%. Take a look! Check us out on Facebook -- and feel free to ask us questions: http://www.facebook.com/BoomBustRT https://www.facebook.com/harrison.writedowns https://www.facebook.com/erinade2020 https://www.facebook.com/biancafacch Follow us @ https://twitter.com/AmeeraDavid http://twitter.com/ErinAde http://twitter.com/edwardnh\ https://twitter.com/BiancaFacchinei
Просмотров: 11138 Boom Bust
Apotex International - An Overview
 
06:18
Apotex believes that every man, woman and child is entitled to affordable medical care and freedom from pain and suffering. For close to 40 years, Apotex has met the healthcare challenges of tomorrow and fought hard to build a successful worldwide pharmaceutical company. Through a strategy of vertical integration, Apotex has built an exceptional scientific and manufacturing base that supports a global sales and marketing infrastructure. We have done this on the heels of our continued commitment to excellence. Apotex is focused on meeting the world’s need for the highest quality, affordable medicines. We have built the facilities, the scientific R&D base, and the technology to meet the healthcare needs of the world for today and tomorrow. With an established network of international affiliates and distributors, our medicines are present in more than 115 countries.
Просмотров: 3703 Apotex Inc.
We need a doctor in US Congress.  Vote Dr Annette Teijeiro NV CD3
 
01:53
Annette Teijeiro understands something about Nevada families and the daily challenges they face. As a medical doctor, she hears their stories every day. Their stories also mirror the stories that Annette's mother and father used to share with her. Before they moved to Las Vegas 39 years ago, they faced similar challenges as Latino immigrants who had endured many years without the opportunities afforded to most Americans. Undeterred, Annette learned at a very young age that commitment, education, and a sense of self-worth can changes lives. While working as a translator for a law firm (starting at 16), she graduated with honors from Bishop Gorman High School. But rather than attend school out of state like many of her peers, Annette enrolled in the University of Nevada, Las Vegas (UNLV), was selected Miss Nevada United Teenager that same year, and became a teaching assistant. Upon graduation, she entered the University of Nevada School of Medicine to become a physician. Annette knew she wanted to be a doctor. She made the decision when she was an athletic trainer for the high school athletic department and understood the value of public service as a volunteer crisis translator for the victims of the tragic fire that engulfed the MGM Grand Hotel in 1980. After days of tireless work, she knew the career she chose would require helping people. Although Annette had to leave Nevada for specialty training in anesthesiology at the University of Washington, Seattle, she always knew she would return home to Nevada. After receiving commendations while attending school and publishing her first paper in the Journal of Anesthesiology, she did return to open a successful private practice and become deeply involved within the community she loved. Since 1996, Annette has not only distinguished herself in the medical profession, but also within the fields of education and legislation. She has been recognized for countless contributions to her community, state, and country. In addition to raising three children with her husband of 24 years, Annette still finds time to serve her community outside of the medical profession. Her activities have ranged from volunteering with United Way to serving on the board of her local homeowner's association. She feels very strongly that the representatives in Congress need to represent the people they serve and not beholden to special interests. Her political campaign is utilizing social media to help raise campaign funds and social awareness. She does not want to rely on lobbyists to buy her votes. She would like to have a broad donor base and if you feel compelled to contribute as little as $20 to her campaign, please go to http://friendsforannette.com/donate.htm Dr Annette Teijeiro is running against Michael Roberson, Danny Tarkanian and Andy Matthews. Steve Sebelius of the Review Journal writes: "Danny Tarkanian is a four-time loser when it comes to politics. Sure, he‘€™s won a couple of Republican primaries, but in the clutch, Tarkanian has always come up short. As one Review-Journal wag put it, Tarkanian‘s last big win came when he was lacing up his sneakers for the Runnin‘ Rebels. But look closely at the numbers and you‘€™ll see Tarkanian always made his races competitive, never embarrassing himself and never descending to the level of perennial also-rans. Still, he‘€™ll have to overcome a lot of history to be successful in his latest bid for office: the Republican primary for the 3rd Congressional District." Grover Norquist, founder of the right-wing think tank Americans for Tax Reform, tweeted about Michael Roberson’s vote on “29 tax hike bills in 2015. Every last one of them.” Norquist added, “Politicians face a choice. Reform government to cost less or raise taxes and keep doing everything the same as always. Reform or Tax.” Roberson, who signed the pledge in 2010, was influential in passing the state’s more than $1.3 billion tax hike in the 2015 legislative session, along with other measures to bolster state spending. Andy Matthews, the former head of a conservative think-tank NPRI.
Просмотров: 5 Annette for Congress
Datacamp - R for Pharmaceutical Analysis
 
02:13
This is a draft video from our upcoming series currently being recorded for Datacamp. Here, Andy Nicholls, Mango's Head of Consulting, gives us an overview of 'Sorting'. The final course should be available on Datacamp in the next few months. It's a work in progress and we're aware of the audio problems
Просмотров: 521 Mango Solutions
Variable Data Printing for Custom Labels
 
02:02
When ordering labels you may have a need to keep the design the same, but switch out the text, numbers, or colors within the same run. Variable Data Printing gives you an efficient, flexible option to print different elements onto your custom labels within a single print run. For more information: http://www.consolidatedlabel.com/capabilities/specialty-labels/variable-data-printing/ Consolidated Label is a multi-award-winning product label manufacturer. The industry term for what we do is “narrow web converter”, converting raw stock materials into labels. We print labels for nearly every industry, including food, beverage, household, cosmetic, medical and pharmaceutical. We specialize in pressure-sensitive labels, shrink sleeves, clear labels, multi-layers, recyclable labels, flexible packaging, QR codes and much more. Our flexographic and digital presses can perform at high and low volume, and we can also handle complex processes like cold foil stamping and doming. Visit our website at http://www.consolidatedlabel.com for more information for a free quote, or call us today: 1-800-475-2235.
Просмотров: 948 Consolidated Label Co.
Pap and RFK, Jr. Interview With Helen Thomas and the Evolution of The Media - The Ring Of Fire
 
10:53
Ring of Fire looks back at an interview with "The First Lady of the Press”, Helen Thomas.  Mike Papantonio and Robert F. Kennedy, Jr. discuss the evolution of the media with Helen and talk about her career in the White House Press Corp from President John F. Kennedy to Barack Obama. Follow more of our stories at http://www.RingofFireRadio.com Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content! Listen to Ring of Fire on Saturdays from 3pm - 6pm Eastern! Listen live via the Progressive Voices Channel on TuneIn: http://tunein.com/radio/Progressive-Voices-s189055/ Or find a station here: http://www.ringoffireradio.com/station/ Watch Ring of Fire every weekday at 8:30pm EST on Free Speech TV! Support Ring of Fire by subscribing to our YouTube channel: http://www.youtube.com/user/golefttv You can also support us here: http://www.ringoffireradio.com/support/ Your continued support keeps Ring of Fire on the air! Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Support us further by shopping on Amazon via our Amazon-Ring of Fire partnership link. A portion of the sales will come back to Ring of Fire at no extra cost to you. Bookmark and follow the link below and continue shopping as usual! Amazon - Ring of Fire partnership link: http://www.amazon.com/?tag=rinoffir-20
Просмотров: 800 The Ring of Fire
9-1-2015 Brandy Vaughan with Patrick Timpone - Profitable Vaccination with No Liability
 
01:00:12
Source of FULL interview with Patrick Timpone on One Radio Network http://oneradionetwork.com/health/brandy-vaughan-targeted-and-harassed-for-speaking-out-about-forced-vaccination-exposing-what-they-dont-want-the-public-to-know-september-1-2015/ http://www.StopMandatoryVaccination.com MORE: Vaccine Industry's Lies Exposed by an Insider - Brandy Vaughan Interview https://www.youtube.com/watch?v=d6VxikBXcdg The Council for Vaccine Safety is a non-profit organization, founded by a former pharmaceutical representative, aiming to raise awareness of vaccine risks through public education. Let’s face it, we have a broken vaccine system in the US. Toxic vaccines, given in record numbers, are harming our children at epidemic proportions. Yet, as long as vaccines are the only products in the US with complete federal liability protection, there are absolutely no incentives for vaccine makers, aka pharmaceutical companies, to change the way they do things. http://councilforvaccinesafety.org/ -Brandy gives us some background about when she worked at Merck and the scandal and lawsuit about the safety of Vioxx -Vaccine studies are substandard; Brandy tells us why -The ingredients in vaccinations are dangerous; the vaccine makers are not held liable -America gives twice as many vaccines as other developed countries and has a higher infant mortality rate, SIDS rates and chronic health problems among children, like asthma, eczema, allergies, etc. -They’re coming for the adults next; what does this mean? -Why we need to get corporate money out of politics -Outlawing direct to consumer marketing and lobbyists would be a real game changer -Brandy tells us about her non-profit Council for Vaccine Safety: The Council for Vaccine Safety is a non-profit organization, founded by Brandy Vaughan, a former pharmaceutical representative, aiming to raise awareness of vaccine risks through public education. Let’s face it, we have a broken vaccine system in the US. Toxic vaccines, given in record numbers, are harming our children at epidemic proportions. Yet, as long as vaccines are the only products in the US with complete federal liability protection, there are absolutely no incentives for vaccine makers, aka pharmaceutical companies, to change the way they do things. -The intimidation and harassment Brandy has experienced in the past months since she took on SB277 -If you live in CA, you may want to visit www.SB277referendum.com –www.safevax.org is the easy way to get to The Council for Vaccine Safety
Просмотров: 788 Abel Danger
POLICE DEPT. EXPOSE BIG PHARMA SALARIES BUT, WHAT IF IT WAS US?
 
06:51
From an article on Activist Post- fair use: This is great. Great in the sense someone is actually DOING something to combat this constant and ever growing TYRANNY. This police dept. exposed the names, e-mail addresses, and phone numbers of some of America's biggest drug dealers. Great job! I agree absolutely and 100%. So, what's my problem? I thought this goverment was going after whistleblowers? Like Snowden and what's his...err...HER name? I cannot help but, wonder, if WE did this, would we just make the pages of Activist Post or would we be asking Snowden to scoot over?
Просмотров: 18 Medical Menudo420
How Much Does A Sales Rep Make.. You will be surprised..
 
04:39
http://www.workwithmikezacher.com --How Much Does A Sales Rep Make. So your thinking about being a sales rep? I can answer your question.. Been a sales rep for quite a while and you should listen to what I will have to say.. help answer your question.. https://www.youtube.com/watch?v=IfuR5OBoZ8g
Просмотров: 73 mike zacher
Sales Representative T-Shirt & Hoodie
 
03:28
Sales Representative T-Shirt & Hoodie ►►►Click Here for More Info: ►►► http://bit.ly/sales-representative-shirts T-Shirt for Sales Representative at DonaShirts.com ►►► http://bit.ly/sales-representative-shirts From Funny T-shirts to Geek tshirts, and everything in between, we have the perfect personalized top just for you! Browse our amazing selection of custom Funny t-shirts designs, or create your new favorite t-shirt from scratch. No minimums, order produced in 24 hours, and 100% satisfaction guaranteed. Sales Representative sales representative jobs sales representative salary sales representative resume sales representative definition sales representative agreement sales representative duties sales representative cover letter sales representative skills sales representative interview questions sales representative salesforce salary sales representative jobs from home sales representative salesforce sales representative pharmaceuticals sales representative titles sales representative bls sales representative average salary sales representative jobs salary sales representative requirements sales representative agreement sample sales representative agreement pdf sales representative aflac sales representative at salesforce sales representative association sales representative advertisement sales representative annual salary sales representative act sales representative ad sales representative accomplishments sales representative agency sales representative adidas sales representative adp sales representative at sprint sales representative articles sales representative attire sales representative act illinois sales representative assessment sales representative benefits sales representative business plan sales representative base salary sales representative buffalo ny sales representative beer sales representative books sales representative business card sales representative bonus structure sales representative bureau of labor statistics sales representative beauty industry sales representative base salary plus commission sales representative budweiser sales representative business code sales representative beauty products sales representative business sales representative baby products sales representative behavioral interview questions sales representative bloemfontein sales representative brisbane About this product: Sales Representative: Awesome, Amazing, Cheap, Best, Top, Funny, Buy, Discount, Coupon, Sale off, Order, Reviews, Amazon, eBay, Teespring, SunfrogShirts, Fabrily, Alibaba, Levi, Macys, 1saleaday, Lacoste, Tommy Tee for Men, for Women, for Girl, Men's, Women's, Girl's...) - Sales Representative Sweatshirts, Wholesale Uk Us Ca Au...Make Tee Customized Shirts Pullover Vintage Volcom Printing Factory Wholesale Maker Tuxedo Design Couple, Zips Crewnecks Sweatpants Loungewear Scrubs Activewear Jackets Polos Tank Tops Ties V-Neck at DonaShirts.com ► http://bit.ly/sales-representative-shirts Delivery: Unated State (Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin), Canada, Unated Kingdom, Austalia....And Global Shipping! Color & Style: Antique Royal Antque Cherry Red Antque Irish Green Ash Grey Azalea Black Blue Dusk Cardinal Red Carolina Blue Charcoal Cherry Red Chestnut Citrus Yellow Cornsilk Daisy Dark Chocolate Dark Heather Forest Green Galapagos Blue Gold Heather Cardinal Heather Indigo Heather Navy Heather Sapphire Heliconia Honey Ice Grey Indigo Blue Iris Irish Green Jade Dome Kelly Green Key Lime Kiwi Light Blue Light Pink Lime Maroon Metro Blue Military Green Mint Green Natural Navy Olive Orange Orchid Paprika Pistachio Prairie Dust Prepared For Dye Purple Red Royal Rusty Bronze Safety Green Safety Orange Safety Pink Sand Sapphire Serene Green Sky Sport Grey Stone Blue Tan Tangerine Texas Orange Vegas Gold White. Order Sales Representative - Read More Customer Reviews, Buy Sales Representative - Get a Big Discount Coupon, Discount Sales Representative- Compare with Relative Products, Purchase Sales Representative - Expert's Recommendation, Find Sales Representative- Read More Product Information, Sales Representative Funny T Shirts Awesome Hoodies Best Sweatshirts Cute Zip Up Cheap Crewnecks Cotton Sweatpants Cool Sleeve Loungewear Scrubs Activewear Jackets Polos Tank Tops Ties V-Neck Clothing Online.